Ahlada Engineers Limited has informed the Exchange regarding Resignation of Mr Bhaskara Reddy Nallapureddy as Independent Director of the company w.e.f. January 23, 2021.

Ajooni Biotech Limited has informed the Exchange regarding 'Outcome of the Board Meeting held on 23rd January 2021, Saturday.'.

Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on January 23, 2021. 1. Increase in Authorised Capital 2. Issue of Bonus Shares 3. Migration of the company from SME platform to Main Board of NSE. 3. Approval of Postal Ballot Notice. 4. Appointment of Scrutiniser. 5. Approval of Cut-off date

Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on January 23, 2021. 1. Increase in Authorised Capital 2. Issue of Bonus Shares 3. Migration of the company from SME platform to Main Board of NSE. 3. Approval of Postal Ballot Notice. 4. Appointment of Scrutiniser. 5. Approval of Cut-off date

Baba Agro Food Limited has informed the Exchange regarding Board meeting held on January 22, 2021.

South West Pinnacle Exploration Limited has informed the Exchange regarding 'Submission of Newspaper Advertisement pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Vertoz Advertising Limited has informed the Exchange regarding 'Intimation of incorporation of branch of our Subsidiary Company in New Jersey, USA'.

Airan Limited has informed the Exchange regarding 'Certificate under Regulation 74 (5) of SEBI ( Depositories and Participants)Regulations, 2018 for the quarter ended 31st December, 2020'.

Preferential Issue of shares Inter alia, to consider and approve further issue of Shares/ other convertible securities on preferential basis.

With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Midodrine Hydrochloride Tablets USP, 2.5 mg, 5 mg, and 10 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform you that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors have appointed Mr. Rajender Parshad Indoria as additional director (Non-Executive Independent Director) w.e.f. 22nd January, 2021 to hold the office till the conclusion of Next Annual General Meeting and will be appointed regular Independent Non Executive Director for five consecutive years, subject to approval of members in the ensuing Annual General Meeting. Details along with the brief profile as per regulation 30 enclosed herewith as annexure-1. The same is for your kind information and record.

With reference to the captioned subject, we would like to inform that Aster DM Healthcare Limited ('the company') has entered into a share subscription agreement to invest in 15.98% of equity share capital of Alfaone Medicals Private Limited. The details required as per Circular Number CIR/CFD/CMD/4/2015 dated September 09, 2015 pertaining to continuous disclosure requirements for Listed Entities under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, has been enclosed as Annexure I. We request you to kindly take the above information on record.

Board of Directors to consider Buy-back of equity shares. Further to our intimation dated December 31, 2020, this is to inform you that the Board of Directors in its meeting scheduled on January 29, 2021 will, inter alia, consider a proposal for Buy-back of equity shares of face value of ` 10/- each of the Company. As informed to the Stock Exchanges on December 31, 2020, trading window for trading in securities of the Company is closed from January 01, 2021 to January 31, 2021 (both days inclusive) in view of the Board Meeting. We request you to inform the members of the Exchange accordingly.

inter alia, approved 1. Appointed Shri Abburi Sidhartha Sagar (DIN: 02312563) as and Additional Director of the Company wef 1st March, 2021. 2. Accepted the Resignation of Shri Raghu Prasad Pidikiti (DIN: 01660157), Non Executive Director of the Company wef 22nd January,2021.

In terms of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we wish to inform you that Shri Raghu Prasad Pidikiti (DIN: 01660157) vide his letter dated 22nd January, 2021 has resigned from the Board of the Company as Director (Non-Executive, Non-Independent) with effect from close of business hours of 22nd January,2021.

Baba Agro Food Limited has informed the Exchange regarding Board meeting held on January 22, 2021.

Intimation of Sad Demise of Ms. Jimisha Parth Dawda, Company Secretary and Compliance officcer of the Company.

The Exchange has sought clarification from Banco Products (India) Ltd on January 22, 2021, with reference to Movement in Volume. The reply is awaited.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and as per above captioned subject we hereby like to inform you that Registrar of Companies has reserved new name for change of name of the company from from "SUN TECHNO OVERSEAS LIMITED to BIOGEN PHARMACHEM INDUSTRIES LIMITED". In view of the above please find enclosed herewith Name Availability Approval Letter received from ROC.

inter alia,approved 1. Appointment of Mr. Gagan Harsh Sharma (DIN: 07939421) as an Additional Director (Executive Director) of the Company w.e.f. January 21, 2021.